We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$41.1B
AUM Growth
+$5.37B
(+15%)
Cap. Flow
+$2.44B
Cap. Flow
% of AUM
5.94%
Top 10 Holdings %
Top 10 Hldgs %
24.49%
Holding
1,526
New
158
Increased
755
Reduced
338
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$170M |
| 2 |
Tesla
TSLA
|
+$155M |
| 3 |
NVIDIA
NVDA
|
+$116M |
| 4 |
TSMC
TSM
|
+$87.6M |
| 5 |
Nutrien
NTR
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$150M |
| 2 |
Northrop Grumman
NOC
|
+$112M |
| 3 |
Honeywell
HON
|
+$98.1M |
| 4 |
Linde
LIN
|
+$87M |
| 5 |
Uber
UBER
|
+$72.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.6% |
| 2 | Healthcare | 16.16% |
| 3 | Financials | 10.71% |
| 4 | Consumer Discretionary | 9.79% |
| 5 | Communication Services | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Outset Medical
OM
$90.6M
| $915K | ﹤0.01% |
1,333
| – | – |
|
952
LXP Industrial Trust
LXP
$3.58B
| $913K | ﹤0.01% |
+11,663
| New | +$866K |
|
|
SAGE
953
DELISTED
Sage Therapeutics
SAGE
| $913K | ﹤0.01% |
21,770
+500
| +2% | +$20.9K |
|
|
SI
954
DELISTED
Silvergate Capital Corporation
SI
| $912K | ﹤0.01% |
6,000
-400
| -6% | -$68.4K |
|
955
Gold Fields
GFI
$36B
| $901K | ﹤0.01% |
84,510
+11,510
| +16% | +$115K |
|
956
Q2 Holdings
QTWO
$3.95B
| $900K | ﹤0.01% |
+11,500
| New | +$928K |
|
957
BioCryst Pharmaceuticals
BCRX
$2.64B
| $894K | ﹤0.01% |
67,065
+1,800
| +3% | +$23.8K |
|
958
Fox Class B
FOX
$23.2B
| $892K | ﹤0.01% |
26,041
-7,376
| -22% | -$270K |
|
959
Janux Therapeutics
JANX
$1.01B
| $892K | ﹤0.01% |
+45,000
| New | +$943K |
|
|
NTST
960
NETSTREIT Corp
NTST
$2.02B
| $890K | ﹤0.01% |
39,155
| – | – |
|
961
Lineage Cell Therapeutics
LCTX
$283M
| $887K | ﹤0.01% |
365,500
-184,500
| -34% | -$432K |
|
962
Crocs
CROX
$6.31B
| $885K | ﹤0.01% |
6,743
-2,954
| -30% | -$455K |
|
963
Peloton Interactive
PTON
$2.46B
| $881K | ﹤0.01% |
25,755
+1,426
| +6% | +$87.1K |
|
964
Xerox
XRX
$423M
| $880K | ﹤0.01% |
37,900
| – | – |
|
965
Apple Hospitality REIT
APLE
$3.68B
| $879K | ﹤0.01% |
54,598
-26,572
| -33% | -$420K |
|
966
Anavex Life Sciences
AVXL
$325M
| $868K | ﹤0.01% |
+50,000
| New | +$950K |
|
|
DOC
967
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $867K | ﹤0.01% |
46,344
-63,656
| -58% | -$1.17M |
|
968
uniQure
QURE
$3.12B
| $863K | ﹤0.01% |
42,400
+1,100
| +3% | +$31.5K |
|
|
ZIXI
969
DELISTED
Zix Corporation
ZIXI
| $858K | ﹤0.01% |
101,000
-3,300
| -3% | -$27.2K |
|
970
Watsco Inc
WSO
$13.2B
| $855K | ﹤0.01% |
2,750
| – | – |
|
971
Veracyte
VCYT
$3.73B
| $854K | ﹤0.01% |
22,000
+600
| +3% | +$26.5K |
|
972
The Ensign Group
ENSG
$10.5B
| $851K | ﹤0.01% |
+10,000
| New | +$777K |
|
973
Herbalife
HLF
$1.23B
| $850K | ﹤0.01% |
20,900
| – | – |
|
974
Academy Sports + Outdoors
ASO
$3.07B
| $841K | ﹤0.01% |
20,308
+2,444
| +14% | +$106K |
|
975
Dole
DOLE
$1.23B
| $835K | ﹤0.01% |
+65,300
| New | +$913K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2021 Portfolio in Review
As of Q4 2021, DekaBank Deutsche Girozentrale held 1,526 positions worth $41.1B, up 15% from $35.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
DekaBank Deutsche Girozentrale deployed $2.44B of net new capital in Q4 2021, opening 158 new positions and adding to 755 existing holdings. Its largest new stake was Regal Rexnord: 103,299 shares worth $17.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Visa, an estimated $150M trimmed.
- DekaBank Deutsche Girozentrale's largest Q4 2021 buy was Regal Rexnord: 103,299 shares worth $17.6M.
- DekaBank Deutsche Girozentrale added most to Mastercard in Q4 2021, an estimated $170M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2021 reduction was Visa, cutting an estimated $150M.
- DekaBank Deutsche Girozentrale fully exited Kansas City Southern in Q4 2021, selling an estimated $20.2M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $41.1B portfolio in Q4 2021.
- DekaBank Deutsche Girozentrale opened 158 new positions and closed 110 in Q4 2021.
- DekaBank Deutsche Girozentrale's portfolio value rose 15% quarter-over-quarter to $41.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.